- Exchange: Toronto
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Resverlogix Corp+ Add to Watchlist
RVX:CN0.7300 CAD 0.00000.00%
As of 15:59:59 ET on 04/17/2014.
Company Profile for Resverlogix Corp (RVX)
Resverlogix Corp. is a biotechnology company focused on developing therapies for unmet medical needs. The Company concentrates on cardiovascular disease, cancer, and fibrotic conditions.
Key Executives for Resverlogix Corp (RVX)
|Donald J McCaffreyPresident/CEO/Secretary||Aaron Bradley Cann "Brad"Chief Financial Officer|
|Allan GordonSenior VP:Clinical Development||Gregory WagnerSenior VP:Research & Dev|
|Peter YoungSenior VP:Discovery Research|